Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for HUMIRA
- A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®
- A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge
- Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
- Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis
- Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA Patients
- To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
- Experimental Medicine Studies of Brain and Peripheral Immune Mechanisms for Sickness Behaviours in Patients With Rheumatoid Arthritis
- A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis
- Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease
- Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis
- Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)
- A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas
- Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
- A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis
- A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab
- A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira
- Hidradenitis Suppurativa Patient Experience With Humira Treatment
- Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.
- Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders
- Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
- Control Crohn Safe Trial
- Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)
- Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
- Personalized Therapies in Inflammatory Complex Disease
- Effects of Abatacept on Myocarditis in Rheumatoid Arthritis
- Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects
- Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis
- A Study Of CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects
- An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis
- Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS
- MAP Study: Methotrexate and Adalimumab in Psoriasis
- The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis
- Repurposing Anti-TNF for Treating Dupuytren's Disease
- Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA
- MSB11022 in Moderate to Severe Rheumatoid Arthritis
- MSB11022 in Healthy Subjects
- Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
- Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)
- BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity
- Reduce Risk for Crohn's Disease Patients
- Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis
- Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically
- Triple Combination Therapy in High Risk Crohn's Disease (CD)
- Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
- A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
- Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis
- BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
- MSB11022 in Moderate to Severe Chronic Plaque Psoriasis
- A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate
- Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis
- Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)
- A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers
- Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis
- Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA)
- Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
- IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
- Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study
- Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI
- A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients
- Comparative Clinical Study of Pharmacokinetics, Tolerance and Safety of BCD-057 and Humira in Healthy Volunteers
- Treatments Against RA and Effect on FDG-PET/CT
- Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept
- Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)
- A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
- Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial
- Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects
- Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis
- Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study
- Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115
- A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
- A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
- A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
- The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients
- BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
- Clinical Trial Using Humira in Netherton Syndrome
- Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
- Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
- Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease
- Targeted Ultrasound in Rheumatoid Arthritis
- Bone Resorption, Osteoclastogenesis and Adalimumab
- A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
- Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
- Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients
- Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)
- Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease
- Vascular Inflammation in Psoriasis - Extension Study
- Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis
- Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)
- Swiss Dermatology Network of Targeted Therapies (SDNTT)
- Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis
- Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)
- Adalimumab in the Treatment of Chronic Pouchitis
- Adalimumab for the Management of Post-operative Crohn's Disease (CD)
- Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis
- Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants
- Adalimumab-psoriasis and Small Bowel Lesions
- Vascular Inflammation in Psoriasis Trial (The VIP Trial)
- RHYTHM (Formerly Escape II Myocardium)
- Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
- Efficacy of Humira in Behcet Patients With Arthritis
- HUmira in Psoriatic Arthritis
- Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.
- Efficacy Study of Adalimumab to Treat Interstitial Cystitis
- The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.
- A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate
- Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease
- A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis
- Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)
- A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)
- Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea
- Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing
- A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis
- A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
- Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule Endoscopy
- Efficacy and Safety of Adalimumab in Patients With Active Uveitis
- Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
- Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study
- A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
- T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
- Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy
- Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
- Mechanism of Action Study for Psoriasis
- Abatacept Versus Adalimumab Head-to-Head
- Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept
- Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa
- A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis
- Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
- A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis
- Bone Resorption, Osteoclastogenesis and Adalimumab
- A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission
- Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
- Juvenile Idiopathic Arthritis (JIA) Registry
- Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use
- A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy
- Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With Humira
- Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis
- Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis
- Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's
- Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis
- Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum
- Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
- Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis
- Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum
- A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy
- Adalimumab for Inflammatory Osteoarthritis
- Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA)
- Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing
- Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis
- Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy
- Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment
- A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis
- Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis
- Adalimumab in Severe and Acute Sciatica
- Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
- Use of Thalidomide in Chronic Uveitis
- Trial of Adalimumab in Progressive Sarcoidosis
- HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis
- Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis
- Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis
- Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis
- Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.
- Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis
- Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)
- Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)
Clinical trials list
click for details